New imaging technique could reveal how well cancer immunotherapy works
NCT ID NCT04260256
First seen Apr 08, 2026 · Last updated May 16, 2026 · Updated 6 times
Summary
This study tested a new type of PET scan that tracks immune cells in people with advanced solid tumors who are receiving checkpoint inhibitor therapy. The goal was to see if the scan could show how well the immune system is attacking the tumor. Only 9 people were enrolled before the study was ended early.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORRELATE TRACER UPTAKE TO TCELL TUMOR INFILTRATION & CKIT BENEFIT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oregon Health and Science University
Portland, Oregon, 97239, United States
-
Stanford University
Stanford, California, 94305, United States
Conditions
Explore the condition pages connected to this study.